Brompheniramine maleate
- Level
- Commodity
- Parent
- 51313400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313418This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H19BrN2.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IXA7C9ZN03, chemically known as 3-(p-bromophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine but more generally known as brompheniramine maleate, which bears US NIH Compound Identifier 6834. European Medicines Agency schedules Brompheniramine maleate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00881MIG. Most nations, for tariff and trade purposes, schedule brompheniramine maleate under HS 29333999 and SITC 51574. As of Q4 2014, BROMPHENIRAMINE MALEATE remains US FDA's Preferred Term for this commodity. Brompheniramine maleate bears US NLM identifiers UMLS ID C0012385 and NCI Concept Code C47422. SMILES: CN(C)CCC(C1CCC(CC1)BR)C2CCCCN2.C(=C\C(=O)O)\C(=O)O.
Same parent
Under 51313400 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.